公司資料
Acutus Medical 股價、新聞與催化劑
- 股票代碼:
- AFIB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (-50.00%)
收盤價
最後更新: 2026年8月12日
—
市值
股價為何變動
Current closing-price context is not available for AFIB.
公司概覽
業務概覽
Acutus Medical is a medical technology company focused on electrophysiology mapping and ablation tools for cardiac arrhythmia procedures. Its business is tied to device adoption in interventional cardiology rather than drug development.
所在地與產業分類
Acutus Medical is headquartered in the United States and listed on NASDAQ, with a medtech profile centered on electrophysiology. It sits outside biotechnology.
商業模式特徵
The company depends on procedure volume, device placements, reimbursement, and the ability to prove that its tools improve workflow in EP labs. Investors usually focus on adoption, capital sales, and execution risk.
生技產業定位
Acutus belongs to the cardiac-device layer of healthcare, not biotech. Its stock is driven by medtech commercialization and clinical adoption rather than by trial data or approvals.
未來催化劑
- Acutus Medical’s catalysts are EP mapping and ablation system adoption, plus any strategic update that clarifies whether the business can stabilize. The market will care about procedural utilization.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。